The summary of the GLINT Periodic Reporting for period 2 is now available on CORDIS.
Read up on the work performed during this period and find out about the significant progress the project has made. The main results achieved so far include:
- A new data acquisition technique (snap-shot CEST) was developed and applied to volunteers and patient.
- A software using Olea Sphere® Software Development Kit (SDK) was developed for CEST data processing.
- The first part of nonclinical safety studies reports has been concluded for a GMP-like batch of 3OMG
- The first-in-man studies in glioma (brain cancer) patients produced positive signal.
